NSE: RAINBOW | BSE: 543524

Mid-range Performer

Download real time

1338.20 -17.80 (-1.31%)

18,683 NSE+BSE Volume

NSE 01 Oct, 2025 10:23 AM (IST)

13,590.7

Market Cap

Above industry Median

0.5

Beta 1Year

Very Low volatility

Rainbow Childrens Medicare Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for RAINBOW, BSE:543524 Rainbow Childrens Medicare Ltd.

Search Inside the pdf :

Rainbow Childrens Medicare Ltd.

30 Sep 2025, 12:00AM

1338.20

-1.31%

Initiating Coverage:Rainbow Child.

Buy: Rainbow Childrens Medicare...

Axis Direct

We initiate coverage on Rainbow Children's Medicare with a BUY recommendation and a DCF based Target Price (TP) of Rs 1,625/share (EV/EBITDA of 23x H1FY28E EBITDA), implying an upside of 20% from the CMP.

Axis Direct released a Buy report for Rainbow Childrens Medicare Ltd. with a price target of 1625.0 on 30 Sep, 2025.

Rainbow Childrens Medicare Ltd.

28 Jul 2025

1338.20

-1.31%

Rainbow Children's Medicare (RAINBOW IN) Q1FY26 Result Update ...

Buy: Rainbow Childrens Medicare...

Prabhudas Lilladhar

Total ~350 beds are expected to become operational in FY26 Rs1.04bn, in line with our estimates. RAINBOW enjoys higher margins, strong asset-light hub-and-spoke model, it being the only integrated multi-specialty pediatric hospital chain in India offering comprehensive services, and its fulltime doctor engagement model. Strategic expansion across its core markets in...

Rainbow Childrens Me.. has an average target of 1682.50 from 4 brokers.

Rainbow Childrens Medicare Ltd.

26 May 2025

1338.20

-1.31%

Rainbow Children's Medicare (RAINBOW IN) Q4FY25 Result Update ...

Buy: Rainbow Childrens Medicare...

Target

Prabhudas Lilladhar

RAINBOW's Q4FY25 consolidated EBITDA grew by 9% YoY (down 15% QoQ) to Rs1.15bn, but 5% below our estimates due to weaker occupancy. RAINBOW enjoys higher margins, strong FCF generation with net cash B/S, and healthy...

Axis Direct released a Buy report for Rainbow Childrens Medicare Ltd. with a price target of 1625.0 on 30 Sep, 2025.

Rainbow Childrens Medicare Ltd.

10 Feb 2025

1338.20

-1.31%

In-line quarter; execution delay a slight dampener

Buy: Rainbow Childrens Medicare...

Emkay

Rainbow’s Q3FY25 print was largely in line with our estimates as revenue/EBITDA grew 18%/14% YoY, respectively. Ramp up in new hospitals remains strong with breakeven expected for Hyderabad hospitals (commissioned during Q4FY24) within the next quarter.

Rainbow Childrens Me.. has an average target of 1682.50 from 4 brokers.

Rainbow Childrens Medicare Ltd.

10 Feb 2025

1338.20

-1.31%

Volume-led growth, expansion plans on track; maintaining a Buy

Buy: Rainbow Childrens Medicare...

Anand Rathi

Broadly in line with the consensus and ARe, Rainbow Children’s Medicare reported reasonable Q3 figures with revenue/EBITDA/PAT up 19%/14%/11% y/y.

Rainbow Childrens Medicare Ltd. is trading below all available SMAs

Rainbow Childrens Medicare Ltd.

10 Feb 2025

1338.20

-1.31%